Orchid Pharma Limited (ORCHPHARMA)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
307.8
-9.65(-3.04%)

Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of bulk actives, formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins, veterinary products, and non-antibiotics. The company also provides anti-infectives, anti-inflammatory, central nervous system, cardiovascular segment, nutraceuticals, and other oral and sterile products, as well as offers new drug discovery systems and pharmaceutical research and development services. It also exports its products to approximately 40 countries internationally. The company was formerly known as Orchid Chemicals & Pharmaceuticals Limited and changed its name to Orchid Pharma Limited in October 2015. Orchid Pharma Limited was incorporated in 1992 and is headquartered in Chennai, India. Orchid Pharma Limited is a subsidiary of Dhanuka Laboratories Limited.

Pricing Updates

TODAY'S HIGH

314

TODAY'S LOW

285.75

52 WEEK HIGH

1525

52 WEEK LOW

265

Major Holders

% of Shares Held by
All Insider

91.73%

% of Shares Held by
Institutions

2.45%

% of Float Held by
Institutions

29.64%

Number of Institutions
Holding Shares

1

Company Overview

MARKET CAP

1256.32 Cr.

ETERPRISE VALUE

1575.15 Cr.

NO. OF SHARES

4.08 Cr.

BOOK VALUE

164.899

DIV. YIELD

3%

DEBT

301.35 Cr.

GROSS PROFIT

0

CASH

20.57 Cr.

REVENUE

500.98 Cr.

REVENUE/SHARE

123.103

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments066.85 Cr.147.17 Cr.37.22 Cr.
Change To Liabilities017.93 Cr.7.69 Cr.-57.67 Cr.
Total cashflows from Investing Activities067.20 Cr.167.11 Cr.45.47 Cr.
Net Borrowings0-125.08 Cr.-290 Cr.-290 Cr.
Total Cash from Financing Activities0-164.98 Cr.-250.33 Cr.-29.96 Lakhs
Other Liabilities060.63 Cr.-3.88 Cr.-67.58 Cr.
Total Assets0040 Cr.40 Cr.
Net Income0-116.53 Cr.-131.07 Cr.69.40 Cr.
Change in Cash0-74.19 Cr.-2.41 Cr.57.19 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities023.58 Cr.80.80 Cr.12.02 Cr.
Depreciation0108.88 Cr.117.90 Cr.127.72 Cr.
Other Cashflows from Investing Activities067.07 Lakhs24.17 Cr.14.86 Cr.
Dividends Paid0000
Change to Inventory0-33.49 Cr.14.06 Cr.23.96 Cr.
Change to Account Receivables0-82.02 Cr.44.01 Cr.-9.14 Cr.
Other Cashflows from Financing Activities0-39.90 Cr.-32.53 Lakhs-29.96 Lakhs
Change to Net Income068.15 Cr.32.06 Cr.-76.88 Cr.
Capital Expenditures0-60.40 Lakhs-4.24 Cr.-6.62 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax0-95.24 Cr.-69.69 Cr.69.40 Cr.
Minority InterestNoneNoneNoneNone
Net Income0-50.57 Cr.-72.17 Cr.-80.04 Cr.
Selling General Administrative068.61 Cr.86.34 Cr.94.49 Cr.
Gross Profit0208.76 Cr.259.80 Cr.307.40 Cr.
Ebit0-50.57 Cr.-72.17 Cr.-80.04 Cr.
Operating Income0-50.57 Cr.-72.17 Cr.-80.04 Cr.
Other Operating Expenses081.80 Cr.127.70 Cr.163.01 Cr.
Interest Expense0-51.33 Cr.-4.15 Cr.-29.96 Lakhs
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense0000
Total Revenue0450.06 Cr.483.80 Cr.599.98 Cr.
Total Operating Expenses0500.63 Cr.555.97 Cr.680.02 Cr.
Cost of Revenue0241.29 Cr.224 Cr.292.57 Cr.
Total Other Income Expense Net0-44.67 Cr.2.48 Cr.149.45 Cr.
Discontinued Operations0-21.28 Cr.-61.37 Cr.-61.37 Cr.
Net Income from Continuous Ops.0-95.24 Cr.-69.69 Cr.69.40 Cr.
Net Income Applicable to Common Shares0-116.53 Cr.-131.07 Cr.69.40 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets036.86 Lakhs24.77 Cr.35.15 Cr.
Capital Surplus0464.47 Cr.464.47 Cr.464.47 Cr.
Total Liabilities0584.34 Cr.693.92 Cr.3781.07 Cr.
Stock Holder Equity0652.90 Cr.765.98 Cr.-704.03 Cr.
Minority Interest0000
Other Liabilities02.56 Cr.1.46 Cr.13.04 Cr.
Total Assets01237.25 Cr.1459.90 Cr.3077.03 Cr.
Common Stock040.81 Cr.40.81 Cr.88.96 Cr.
Retained Earnings0-1471.65 Cr.-1355.72 Cr.-1311.32 Cr.
Other Liabilities014.76 Cr.15.01 Cr.10.92 Cr.
Good Will00094.82 Cr.
Treasury Stock01619.26 Cr.1616.41 Cr.53.84 Cr.
Other Assets09.10 Cr.6.69 Cr.774.68 Cr.
Cash015.69 Cr.89.89 Cr.92.31 Cr.
Current Liabilities0142.08 Cr.174.93 Cr.2345.54 Cr.
Long Term Asset Charges0000
Short Long Term Debt022.40 Cr.62.42 Cr.1109.85 Cr.
Other Stockholder Equity01619.26 Cr.1616.41 Cr.53.84 Cr.
Property Plant Equipment0677.50 Cr.858.77 Cr.1404.44 Cr.
Total Cur. Assets0549.85 Cr.569.32 Cr.767.46 Cr.
Long Term Investments041.77 Lakhs33.82 Lakhs47.21 Lakhs
Net Tangible Assets0652.53 Cr.741.21 Cr.-834.01 Cr.
Short Term Investments080 Lakhs1.22 Lakhs233.20 Cr.
Net Receivables0135.76 Cr.67.97 Cr.122.26 Cr.
Long Term Debt0427.49 Cr.503.97 Cr.1424.60 Cr.
Inventory0152.88 Cr.141.69 Cr.169.77 Cr.
Accounts Payable0109.95 Cr.101.58 Cr.302.44 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account